{"id":498861,"date":"2021-05-26T08:08:18","date_gmt":"2021-05-26T12:08:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/"},"modified":"2021-05-26T08:08:18","modified_gmt":"2021-05-26T12:08:18","slug":"agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/","title":{"rendered":"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">PRINCETON, N.J., May  26, 2021  (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc. (Nasdaq: AGRX), a women\u2019s healthcare company, today announced the company will be participating virtually in the William Blair 41<sup>st<\/sup> Annual Growth Stock Conference.<\/p>\n<p>Chairman and Chief Executive Officer Al Altomari is scheduled to participate in a fireside chat on Tuesday, June 1, 2021 at 10:20 a.m. Eastern Time. The fireside chat will be webcast live and can be accessed in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iyvIzum6ljdd3o4635YWUM2lLo0TCwQ7kkmMIz2qKtDTwemroHKl9_9RtQbjvvZ8uySDhwY9pfdjSc1tUpVAzokftsQPnV3KSArfNfBjIZbjNP2Bra075IyAHupCdTQrxoO0UatoKsTD9Nhmc2GzwQ==\" rel=\"nofollow noopener\" target=\"_blank\">Events and Presentations<\/a> section of the Agile Therapeutics website or by clicking here: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GDlJx5aJ3xf4U3Us-2qtfBN0tcnzWxFWwUGjLQS36n_CxzsWrSPzI7ThK9FGk_1LCwYMiXi3O2O6mnSMd5pH3mtWql8m_N3Jr4yoc9VanaXU-F9WGxSQ-acPyWi9p7vTK1S_sfvBHJxYj11ERoPZCw==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/wsw.com\/webcast\/blair58\/agrx\/1940510<\/a>.<\/p>\n<p align=\"justify\">The webcast will be archived on the Agile Therapeutics website for 30 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Agile Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.\u00a0Our initial product, Twirla\u00ae, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion\u00ae, which is designed to allow drug delivery through the skin. For more information, please visit the company website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gcSksW95YHjLdthi55RxuJvQXDqfKKZtAWPGNWsKsPOUSMncwbpPEN0yatEfGM_wPAsD-94mx0k0BoZKowC2doQ1gkLV2hfbOx2meh-dibKCG-ulvlMmoJKtNR6TVZA0iBa-7rqAfDHIGa7J2lvF4DZB6BScWU49QB7GuEQjTMTrWArV-alkh_95EsGNBKWTdjGHO62oH5Khpc4Ys7Q2A5TIyeTQUU4EHd3MK5MEwEi7ayrbsR4GCn60RouvtmEfMEWoWNRgLFEkSfMPVa4tucvlEPmoWz9Hbb7alD8skHw=\" rel=\"nofollow noopener\" target=\"_blank\"><strong><u>www.agiletherapeutics.com<\/u><\/strong><\/a>. The Company may occasionally disseminate material, nonpublic information on the Company\u2019s website.<\/p>\n<p>\n        <strong>Contact:<\/strong>\u00a0<br \/>Matt Riley<br \/>Head of Investor Relations &amp; Corporate Communications<br \/><strong><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WhhQqfYbVU17-PCdwhNfQoajGPl3JXAPF91necjjGEMdIQarwky8V_Xmt0lDX7y5Z0UvhZaCeTArX7cyJb_OpMWKqazs7FPJvvWCNUm9Ev9GqnFxWAnWfNkkncSyVArS\" rel=\"nofollow noopener\" target=\"_blank\">mriley@agiletherapeutics.com<\/a><\/u><\/strong><\/p>\n<p>\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/03f580b3-1e32-43f6-9971-19efc0fd5e6b\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., May 26, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc. (Nasdaq: AGRX), a women\u2019s healthcare company, today announced the company will be participating virtually in the William Blair 41st Annual Growth Stock Conference. Chairman and Chief Executive Officer Al Altomari is scheduled to participate in a fireside chat on Tuesday, June 1, 2021 at 10:20 a.m. Eastern Time. The fireside chat will be webcast live and can be accessed in the Events and Presentations section of the Agile Therapeutics website or by clicking here: https:\/\/wsw.com\/webcast\/blair58\/agrx\/1940510. The webcast will be archived on the Agile Therapeutics website for 30 days following the event. About Agile Therapeutics, Inc. Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-498861","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., May 26, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc. (Nasdaq: AGRX), a women\u2019s healthcare company, today announced the company will be participating virtually in the William Blair 41st Annual Growth Stock Conference. Chairman and Chief Executive Officer Al Altomari is scheduled to participate in a fireside chat on Tuesday, June 1, 2021 at 10:20 a.m. Eastern Time. The fireside chat will be webcast live and can be accessed in the Events and Presentations section of the Agile Therapeutics website or by clicking here: https:\/\/wsw.com\/webcast\/blair58\/agrx\/1940510. The webcast will be archived on the Agile Therapeutics website for 30 days following the event. About Agile Therapeutics, Inc. Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs &hellip; Continue reading &quot;Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-26T12:08:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference\",\"datePublished\":\"2021-05-26T12:08:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/\"},\"wordCount\":242,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/\",\"name\":\"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=\",\"datePublished\":\"2021-05-26T12:08:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/","og_locale":"en_US","og_type":"article","og_title":"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference - Market Newsdesk","og_description":"PRINCETON, N.J., May 26, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc. (Nasdaq: AGRX), a women\u2019s healthcare company, today announced the company will be participating virtually in the William Blair 41st Annual Growth Stock Conference. Chairman and Chief Executive Officer Al Altomari is scheduled to participate in a fireside chat on Tuesday, June 1, 2021 at 10:20 a.m. Eastern Time. The fireside chat will be webcast live and can be accessed in the Events and Presentations section of the Agile Therapeutics website or by clicking here: https:\/\/wsw.com\/webcast\/blair58\/agrx\/1940510. The webcast will be archived on the Agile Therapeutics website for 30 days following the event. About Agile Therapeutics, Inc. Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs &hellip; Continue reading \"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-26T12:08:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference","datePublished":"2021-05-26T12:08:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/"},"wordCount":242,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/","name":"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=","datePublished":"2021-05-26T12:08:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI0MzA3NSM0MjAxOTc4IzIwMDc5MTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-participate-in-the-william-blair-41st-annual-growth-stock-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/498861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=498861"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/498861\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=498861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=498861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=498861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}